BRIEF—Portage invests in French cancer immunotherapy company

11:37 EST 28 Feb 2018 | thePharmaLetter

Canada’s Portage Biotech has made an investment in Stimunity, a Paris, France-based immuno-oncology

Original Article: BRIEF—Portage invests in French cancer immunotherapy company

NEXT ARTICLE

More From BioPortfolio on "BRIEF—Portage invests in French cancer immunotherapy company"